// App-Quantinova.ai

4372 : MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism

Researchers

Presenter

  • Lori Ramkissoon

Principal Investigators

  • Pratiti Bandopadhayay

  • Payal Jain

  • Guillaume Bergthold

  • Adam Resnick

  • Rameen Beroukhim

  • Keith Ligon

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • Childrens Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Low-grade gliomas

  • Solid malignancies

  • Gliomas

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Cyclin dependent kinase 6

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved